Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00658281 · ClinicalTrials.gov registry record

Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients

A clinical trial of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
28
Enrollment target
1
Study location

NCT00658281: Completed study of Breast Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00658281 is a study of Breast Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 28 participants, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00658281, a study of Breast Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
28 participants
Enrollment target
1
Study location

Study Summary

The goal of this clinical research study is to use the On Board Imager kilovoltage (OBI KV) system and cone beam computed tomography (CBCT) scanning or CT-on-rail system to look at how well a routine device called an electronic portal imaging device (EPID) can set up a patient to receive radiation therapy on the lymph nodes in the neck.

Conditions Studied

Interventions

  • PROCEDURE CBCT Scan
  • PROCEDURE OBI KV Imaging

Study Locations (1)

Texas

  • University of Texas MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2008-03
Est. Completion 2014-10

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT00658281

The ClinicalTrials.gov registry entry for NCT00658281 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,803-participant average among 1,224 other Breast Cancer trials with a reported enrollment target (99% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Breast Cancer appearing as the primary indexed condition, and to 2 interventions - of which CBCT Scan is the first listed.

NCT00658281 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT00658281 about?

NCT00658281 is a clinical study titled "Setup Variation in the Supraclavicular Lymph Nodes Treatment in Breast Cancer Patients". The goal of this clinical research study is to use the On Board Imager kilovoltage (OBI KV) system and cone beam computed tomography (CBCT) scanning or CT-on-rail system to look at how well a routine device called an electronic portal imaging device (EPID) can set up a patient to receive radiation t...

What is the current status of trial NCT00658281?

This trial is currently completed. The enrollment target is 28 participants. The study started on 2008-03. Estimated completion is 2014-10.

What conditions does trial NCT00658281 study?

This clinical trial studies the following conditions: Breast Cancer.

What interventions are being tested in trial NCT00658281?

The interventions under investigation include: CBCT Scan (PROCEDURE), OBI KV Imaging (PROCEDURE).

Who is sponsoring clinical trial NCT00658281?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00658281 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Breast Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.